Dave Muoio
A weekend update to the virtual assistant includes a new COVID-19 conversation tree, which relies on information and guidance from the CDC and links users to consumer telehealth services if appropriate.
Nurx, Carbon Health and Everlywell have officially halted their mail-order testing-kit services. But at least one startup is still moving to secure an Emergency Use Authorization for its at-home rapid serology diagnostic.
The temporary policy also extends to some clinical decision support software used in conjuction with these remote monitor devices.
[Since this article was published, the FDA has released an alert warning that it has not yet authorized any COVID-19 home testing kits]
Early data from the roughly 100,000-participant effort suggest infrequent social distancing and regional behavior disparities (as of March 15).
The Series A round will help the Salt Lake City startup solidify its role as an end-to-end patient-billing suite.
The recently announced COVID-19 Open Research Dataset consists of more than 29,000 machine-readable coronavirus articles ripe for analysis.
The company's hybrid in-person and virtual visit approach provides consumers with male hormone replacement therapies and other supplements.
Also: Welltok expands to Latin America with insurer partnership; Kyruus and GYANT combine their offerings for health system clients.
New hires, branding efforts and academic research partnerships are all on the table for the smart ring maker's future.